PFED trade ideas
PFizer D1The disease statistics for the Coronavirus in the world has reached the level of 1,000,000 population. This situation creates enormous problems for the economy and for the life of people in general. But for the PFizer company, this just gives a huge potential for the possibility of earning money on this problem. Because the market has a huge potential for sales. And the bulk of people will be vaccinated with this particular vaccine. And this will be government procurement, which will amount to millions of dollars in revenue for the company. Which will stimulate stocks to grow.
Phizer pulling back nicely to support trendlineShares of Phizer (NYSE:PFE) are pulling back nicely to the trendline going back to March of last year. The share is also touching its 200MA. Results are due on Tuesday next week so Im keeping a close eye on this one. If we get a bounce the share could be on its way back to previous highs reached in November 2018, given a potential return of 20% over the coming year. As a bonus, the share is also a good dividend payer. Pfizers contribution to the vaccine and Covid fight should also provide some long term support.
Looks like PFE it's going to break upFrom the technical point of view, if PFE breaks the resistance level noted in this chart it can go easily over 40$ USD after earnings.
There's no reason to short Pfizer right now. The company got massive amount of money from vaccine pre-orders, investments and probably the earnings will be at last at estimated level.
Pfizer forming a double bottom to continue moving up?Another update on PFE. Price has stalled for some time now around the internal support. We have a divergence with RSI and the price and RSI is starting to move above 50. MACD is making a bullish crossing and the histogram is going positive as well. Volumes are showing buying activity and we have a potential setup for a double bottom. Keep an eye on PFE.
Ex-dividend date - An end to investors' hesitation?Good evening.
Price has remained awfully quiet in anticipation of bad headlines. When those headlines actually arrived (23 elderly patients dead in Norway), they were swept under the rug by media world-wide, or just shrugged off.
Source: Bloomberg - Pfizer Vaccine Safe for Elderly Despite Norway Scare, WHO Says
Price has remained extremely stable around 36.22-37.78$ but the ex-dividend date is 28th of January, which means if investors were looking to buy but were hesitant, they'll have to pull the trigger in the coming 2 days or miss out on the dividends of the quarter. Q4 2020 Earnings report is expected on the 2nd of February.
Might be exactly what PFE needs to break out towards 42.50$ again. Especially considering the company's pledge to make 1.3 to 2 billion doses in 2021.
P.S.: Pfizer is looking at a 50% COVID vaccine earnings split with BioNTech, or even slightly more.
Source: Motley Fool - What Does 2021 Hold for BioNTech Stock?